Clinical Trial Update: Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity and reactogenicity of a pneumococcal conjugate vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: Public Health England | Conditions: Streptococcus Pneumoniae | Phase 2 | Status: COMPLETED